Trials / Recruiting
RecruitingNCT07446114
Functional Outcomes and Control Using Synchron BCI - Canada
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Synchron, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN)
Detailed description
Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN): The Synchron BCI motor neuroprosthesis is an implanted brain-computer interface indicated for adults with bilateral upper-limb motor impairment, including Motor Neuron Disease. The Synchron BCI is intended to replace the function of motor neurons by detecting, translating and transmitting motor-related brain signals to restore clinically meaningful control of digital devices. The Synchron BCI is an implanted BCI device that interfaces with the brain to enable control of digital devices in individuals with bilateral upper-limb motor impairment. The Synchron BCI is designed to record volitional motor-related neural signals from the sensorimotor cortices and translate these signals into digital motor outputs to enable control of digital devices to improve functional independence. The system includes both implantable and non-implantable components. Implantable components are the Stentrode and the Transceiver.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stentrode | The Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices. |
Timeline
- Start date
- 2026-03-18
- Primary completion
- 2026-12-01
- Completion
- 2027-07-01
- First posted
- 2026-03-03
- Last updated
- 2026-04-17
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT07446114. Inclusion in this directory is not an endorsement.